TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| St. Ann’s poised for $100M expansion Mount Carmel Health System plans to add 200 jobs with a $100 million expansion of its St. Ann’s campus over the next three to five years, the hospital system announced Wednesday. feeds.bizjournals.com |
Legal-Pot Backers Split on Timing Proponents of legalizing marijuana in California can't agree on how soon voters will be ready to approve legalization. online.barrons.com |
BioMed News: Rockwell Medical, EXACT Sciences, MannKind Mike Havrilla submits:The BioMedReports.com FDA Calendar service includes a database with over 400 entries of (1) pending new drug, biological agent, or medical device new product decisions at the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, and sBLA filings); (2) pending new submissions to the FDA; (3) pending complete response letter (CRL) re-submissions to the FDA; and (4) pending clinical trial results. On 10/29/09, MannKind (NASDAQ: MNKD) announced that results of two Phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for Phase 2 studies.Complete Story » seekingalpha.com |
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript Peregrine Pharmaceuticals Inc. (PPHM)F2Q10 Earnings CallDecember 10, 2009; 11:30 am ETComplete Story » seekingalpha.com |
Monthly Updates Set for MS Drug Biogen Idec will communicate with doctors once a month on the occurrence of new cases of a rare brain infection in patients using its multiple sclerosis treatment Tysabri. online.wsj.com |